Jane Street’s Tempest Therapeutics TPST Stock Holding History

Jane Street’s Portfolio TPST Stock Details TPST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-37,930	Closed	-$411K	–	10619
2024 Q4	$411K	Buy	+37,930	New	+$490K	﹤0.01%	7178
2024 Q2	–	Sell	-1,618	Closed	-$82.3K	–	10193
2024 Q1	$82.3K	Buy	+1,618	New	+$81.7K	﹤0.01%	8595
2020 Q3	–	Sell	-272	Closed	-$93K	–	7917
2020 Q2	$93K	Buy	+272	New	+$109K	﹤0.01%	6730
2017 Q3	–	Sell	-5	Closed	-$23K	–	5072
2017 Q2	$23K	Buy	+5	New	+$21.2K	﹤0.01%	4252
2017 Q1	–	Sell	-23	Closed	-$101K	–	4691
2016 Q4	$101K	Buy	+23	New	+$287K	﹤0.01%	3872
2015 Q4	–	Sell	-6	Closed	-$138K	–	4481
2015 Q3	$138K	Buy	+6	New	+$404K	﹤0.01%	3305
2013 Q4	–	Sell	-7	Closed	-$195K	–	2893
2013 Q3	$195K	Buy	+7	New	+$248K	﹤0.01%	2424

Other funds holding TPST

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Jane Street's TPST Position: Q1 2025 in Review

Jane Street sold out of Tempest Therapeutics (TPST) in Q1 2025, closing a stake of 37,930 shares — an estimated $411K sold.

Jane Street first reported a position in TPST in Q3 2013 and held it in 7 quarters. The position peaked at $411K in Q4 2024. 23 funds tracked by Wall St. Rank hold TPST as of Q1 2025.

Jane Street reported no remaining Tempest Therapeutics position as of Q1 2025 after selling out during the quarter.
Jane Street sold 37,930 Tempest Therapeutics shares in Q1 2025, an estimated $411K.
Jane Street first reported a position in Tempest Therapeutics in Q3 2013 and held it in 7 quarters.
Jane Street's Tempest Therapeutics position peaked at $411K in Q4 2024.
23 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q1 2025.

Based on Jane Street's 13F filing for Q1 2025, filed 14 May 2025.